Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiteru Shigeno is active.

Publication


Featured researches published by Yoshiteru Shigeno.


Drugs | 1986

Clinical and Bacteriological Evaluation of Branhamella catarrhalis in Respiratory Infections

Atsushi Saito; Keizo Yamaguchi; Yoshiteru Shigeno; Shigeru Kohno; Hideaki Shigeno; Nobuchika Kusano; Yasumasa Dotsu; Kohei Hara

SummaryThe clinical significance of Branhamella catarrhalis in respiratory infections is evaluated. 175 strains were isolated, mainly from the sputum, in 71 patients with respiratory infections. B. catarrhalis was most frequently isolated in mixed infections with Haemophilus influenzae (38.3%), H. influenzae plus Streptococcus pneumoniae (10.3%) or S. pneumoniae (9.7%). The rate of isolation of B. catarrhalis alone was as low as 5.1% and from mixed infections with Pseudomonas aeruginosa, Escherichia coli, and Enterobacter and/or Klebsiella species it was 36.6%. More than 107 cfu/ml of B. catarrhalis were isolated from 71.4% of cases.In 29 cases the organism was determined to be causative according to our criteria, most often in secondary infections in patients with complicated pneumoconiosis, chronic bronchitis and bronchiectasis.29 of 47 strains (61.7%) produced β-lactamase of the penicillinase type. Against these strains, penicillin antibiotics and first and second generation cephalosporin antibiotics (except cefroxadine) showed weak activity compared with their activity against non-β-lactamase- producing strains. The third generation cephalosporins showed a uniform spectrum of activity against both groups of organisms.


Infection | 1985

Respiratory superinfections after the use of third-generation cephem antibiotics

Atsushi Saito; Kenji Mori; Yoshiteru Shigeno; Yamaguchi K; Kohei Hara

SummaryThis paper is a report on our studies on superinfections in respiratory tract infections treated during the years 1981–1984. The isolated strains ofStaphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis, Streptococcus faecium and glucose non-fermentative gram-negative rods such asPseudomonas aeruginosa were resistant to third-generation cephem antibiotics. These organisms proved to be widely distributed in hospitals and were frequently isolated from the sputum, excised lung and cardiac blood. The colonization of the sputum by bacteria in respiratory tract infections before, during and after treatment with third-generation cephem antibiotics revealed a tendency for these organisms to appear after treatment. Among the gram-positive cocci,S. faecium was most resistant to these antibiotics, followed byS. faecalis, S. epidermidis andS. aureus in that order. The incidence of resistant isolates in 1984 exceeded that in 1983, suggesting an annual increase in resistant bacteria.ZusammenfassungWir berichten über unsere Studien zu Superinfektionen bei Infektionen der Atemwege, die von 1981–1984 behandelt wurden. Die isolierten Stämme vonStaphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis undStreptococcus faecium sowie von Glukose nicht fermentierenden gramnegativen Stäbchen wiePseudomonas aeruginosa waren resistent gegen Cephem-Antibiotika der dritten Generation. Es zeigte sich, daß diese Erreger in den Krankenhäusern weit verbreitet waren; sie wurden häufig aus Sputum, Lungenexzisaten und Herzblut isoliert. Untersuchungen zur Kolonisation des Sputums vor, während und nach der Therapie mit Cephem-Antibiotika der dritten Generation ließen eine Tendenz für das Auftreten dieser Bakterien im Anschluß an die Behandlung erkennen. Unter den grampositiven Kokken warS. faecium am resistentesten gegen diese Antibiotika,S. faecalis, S. epidermidis undS. aureus zeigten eine in der genannten Reihenfolge geringgradigere Resistenz. Die Inzidenz resistenter Isolate war 1984 höher als 1983, was auf eine jährliche Zunahme resistenter Bakterien schließen läßt.


Journal of Antimicrobial Chemotherapy | 1986

The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs.

Atsushi Saito; Hironobu Koga; Hideaki Shigeno; Koichi Watanabe; Kenji Mori; Shigeru Kohno; Yoshiteru Shigeno; Yoji Suzuyama; Keizo Yamaguchi; Masaki Hirota; Kohel Hara


Tohoku Journal of Experimental Medicine | 1989

Transthoracic Needle Aspiration of the Lung in Respiratory Infections

Shigeru Kohno; Kouichi Watanabe; Akihiro Hamamoto; Yasumasa Dotsu; Hironobu Koga; Toshiaki Hayashi; Yoshiteru Shigeno; Keizo Yamaguchi; Atsushi Saito; Kohei Hara


The Journal of the Japanese Association for Infectious Diseases | 1991

Serum levels of healthy adult humans and changes of IgG subclass levels between infected and convalescent phase in respiratory infections

Hiroshi Hukuhara; Yoshiteru Shigeno; Atsushi Saito


The Japanese journal of thoracic diseases | 1985

Bacteriological Evaluation of Materials Obtained by Fiberoptic Bronchoscopy in Cases of Pulmonary Infection

Kohei Hara; Keizo Yamaguchi; Yoshiteru Shigeno; Yoji Suzuyama; Akimitsu Tomonaga; Tetsuro Kanda; Kinichi Izumikawa; Masaki Hirota; Atsushi Saito


The Journal of the Japanese Association for Infectious Diseases | 1984

[A case of Legionnaires' disease and Branhamella catarrhalis pneumonia complicated with malignant lymphoma].

Nagasawa M; Nakasato H; Hironobu Koga; Fukuda Y; Koichi Watanabe; Hiroshi Tomita; Katsuhiko Sawatari; Hikaru Tanaka; Kiyo Fujita; Yoshiteru Shigeno


Chemotherapy | 1984

Laboratory and clinical studies on lenampicillin (kbt-1585) A new penicillin antibiotic

Yoshiteru Shigeno; Miyako Masaki; Hiroko Nakazato; Hironobu Koga; Nagasawa M; Hiroshi Tomita; Koichi Watahabe; Yoshiaki Fukuda; Hikaru Tanaka; Akimitsu Tomonaga; Yoji Suzuyama; Kinichi Izumikawa; Atsushi Saito; Kohei Hara; Nobuchika Kusano; Mitsuo Kaku; Kazuyuki Sugawara; Chikako Mochida; Keizo Yamaguchi; Hlroyuki Okada; Akira Ikebe; Kazuhiro Okuno


The Japanese journal of thoracic diseases | 1989

Three case reports of relapsing polychondritis and their immunopathological analysis

Mutsuko Miyagi; Katsunari Akamine; Takao Kuniyoshi; Tomokazu Kakazu; Hiroshi Kaneshima; Hiroaki Nakamura; Y. Irabu; Katsuyoshi Shimoji; K. Kitsukawa; Yoshiteru Shigeno; Yutoku Kinjyo; Atsushi Saito; Takayoshi Toda


The Journal of the Japanese Association for Infectious Diseases | 1987

Comparative Clinical Trial of HBK and Amikacin (AMK) in the Treatment of Respiratory Infections

Hara K; Atsushi Saito; Yamaguchi K; Yoshiteru Shigeno; Taira K; Oda T; Toshiaki Hayashi; Hiroshi Tomita; Masuyama Y

Collaboration


Dive into the Yoshiteru Shigeno's collaboration.

Top Co-Authors

Avatar

Atsushi Saito

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge